RACHEL SCHIFF to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications RACHEL SCHIFF has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.146
-
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial. Breast Cancer Res Treat. 2025 Jul; 212(1):57-69.
Score: 0.146
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.